Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Twelve immunotherapy drugs that could cure cancers.
Cheever MA. Cheever MA. Immunol Rev. 2008 Apr;222:357-68. doi: 10.1111/j.1600-065X.2008.00604.x. Immunol Rev. 2008. PMID: 18364014 Review.
Cancer vaccines and immunotherapies: emerging perspectives.
Henderson RA, Mossman S, Nairn N, Cheever MA. Henderson RA, et al. Among authors: cheever ma. Vaccine. 2005 Mar 18;23(17-18):2359-62. doi: 10.1016/j.vaccine.2005.01.082. Vaccine. 2005. PMID: 15755628
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine.
Disis ML, Schiffman K, Guthrie K, Salazar LG, Knutson KL, Goodell V, dela Rosa C, Cheever MA. Disis ML, et al. Among authors: cheever ma. J Clin Oncol. 2004 May 15;22(10):1916-25. doi: 10.1200/JCO.2004.09.005. J Clin Oncol. 2004. PMID: 15143085 Clinical Trial.
Designing HER2 vaccines.
Foy TM, Fanger GR, Hand S, Gerard C, Bruck C, Cheever MA. Foy TM, et al. Among authors: cheever ma. Semin Oncol. 2002 Jun;29(3 Suppl 11):53-61. doi: 10.1053/sonc.2002.34056. Semin Oncol. 2002. PMID: 12138398 Review.
PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.
Cheever MA, Higano CS. Cheever MA, et al. Clin Cancer Res. 2011 Jun 1;17(11):3520-6. doi: 10.1158/1078-0432.CCR-10-3126. Epub 2011 Apr 6. Clin Cancer Res. 2011. PMID: 21471425
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.
Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM. Cheever MA, et al. Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737. Clin Cancer Res. 2009. PMID: 19723653 Free PMC article.
Translational Research Working Group developmental pathway for immune response modifiers.
Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG; Translational Research Working Group. Cheever MA, et al. Clin Cancer Res. 2008 Sep 15;14(18):5692-9. doi: 10.1158/1078-0432.CCR-08-1266. Clin Cancer Res. 2008. PMID: 18794077 Free PMC article.
Tuberculosis following PD-1 blockade for cancer immunotherapy.
Barber DL, Sakai S, Kudchadkar RR, Fling SP, Day TA, Vergara JA, Ashkin D, Cheng JH, Lundgren LM, Raabe VN, Kraft CS, Nieva JJ, Cheever MA, Nghiem PT, Sharon E. Barber DL, et al. Among authors: cheever ma. Sci Transl Med. 2019 Jan 16;11(475):eaat2702. doi: 10.1126/scitranslmed.aat2702. Sci Transl Med. 2019. PMID: 30651320 Free PMC article.
Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivo.
Cheever MA, Klarnet JP, Peace DJ, Greenberg PD. Cheever MA, et al. Prog Clin Biol Res. 1987;244:49-58. Prog Clin Biol Res. 1987. PMID: 3498958
Requirements for T cell recognition and elimination of retrovirally-transformed cells.
Greenberg P, Klarnet J, Kern D, Okuno K, Riddell S, Cheever M. Greenberg P, et al. Among authors: cheever m. Princess Takamatsu Symp. 1988;19:287-301. Princess Takamatsu Symp. 1988. PMID: 2479634
132 results
Jump to page